Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 76 +0.50 (+0.66%) Sep 1
At Loss
P/B:
8.29
Market Cap:
€ 6.71B ($ 7.77B)
Enterprise V:
€ 5.85B ($ 6.78B)
Volume:
0
Avg Vol (2M):
122.00
Trade In:

Spyre Therapeutics Inc Valuation Measures